07 Jan 2001

Levopar® 62,5 (Levopar® 62,5 mg/-125 mg/-250 mg Kapseln) - Deutschland

Updated: 07 Jan 2001

Levopar® 62,5 mg | -125 mg | -250 mg

Morbus Parkinson, symptomat. Parkinson-Syndr. (ausgenommen medikamentös induzierte Parkins.-Syndr.)

Levopar® 62,5 Description, Presentation and Dosage

Levopar® 62,5 Description

Levopar® 62,5 Drug Class Description


Levopar® 62,5 Drug Description

1 Kps. enth.: Levodopa 50 mg/100 mg/200 mg, Benserazid 12,5 mg/25 mg/50 mg.

Levopar® 62,5 Generic Name

Levopar® 62,5 mg/-125 mg/-250 mg Kapseln

Levopar® 62,5 Presentation

Levopar® 62,5 Presentation

Levopar® 62,5 mg/-125 mg/-250 mg

Levopar® 62,5 Manufacturer

Hexal/Neuro Hexal

Related Learning Zones

Heart Failure

Heart Failure is a progressive chronic disorder that results in the inability of the heart to pump blood efficiently to the bodys tissues.

Chronic heart failure is an increasing public health problem; the growing prevalence in industrialised countries means that 1-2% of the adult population of these countries are now thought to have chronic heart failure.1-3 Estimates suggest that the prevalence in Europe, USA and Japan could increase by approximately 16.5% over the next ten years.4



The Hypogonadism Knowledge Centre gives healthcare professionals free access to resources on the diagnosis, treatment and monitoring of patients with the condition. The regularly-updated publications digest area contains analysis and comment on recent scientific articles related to male hypogonadism.

Levopar® 62,5 Dosage

Levopar® 62,5 Adult Dosage

Lactose 82,35 mg/164,7 mg/329,4 mg, Gelatine, Magnesiumstearat, Natriumdodecylsulfat, Siliciumdioxid, Farbstoffe E 132, E 171, zusätzl. f. Levopar 62,5 mg/-125 mg: Farbstoff E 172.

Levopar® 62,5 Elderly Dosage

1 Kps. entspr. 0,01 BE/0,01 BE/0,03 BE.

Levopar® 62,5 Precautions, Reactions and Contraindications

Levopar® 62,5 Special Precautions

Levopar® 62,5 Special Precautions


Related Drugs - Neurological Disorders

Back to top